pharmaphorum

JANUARY 5, 2021

The post Roche nabs breakthrough tag for TIGIT cancer immunotherapy appeared first on.

Immune Response 52

Immune Response FDA Approval Drugs Sales 52

XTalks

NOVEMBER 3, 2022

In a head-to-head trial, the results of which helped Mounjaro nab its FDA approval, Mounjaro outperformed Novo Nordisk’s Ozempic in controlling blood sugar and helping patients lose weight. The company is currently conducting a study to demonstrate Mounjaro’s weight loss effects and secured an FDA Fast Track tag in the obesity indication.

Sales 98

Sales FDA Approval Production Insulin 98

XTalks

APRIL 18, 2024

Previously, Roche secured an FDA breakthrough tag for another one of its Alzheimer’s blood tests that detects levels of pTau-181 and ApoE4 (apolipoprotein e4). It also nabbed FDA approvals for two pairs of Elecsys in vitro diagnostics for the analysis of amyloid and tau in CSF.

Clinical Trials 52

Clinical Trials Clinical Trials In-Vitro Protein 52

Drug Discovery World

MAY 22, 2023

The cost 2022 has not been shy of approvals – Uniqure and CSL’s Haemophilia B drug even nabbed the title of “Most Expensive Drug” at $3.5 But are these price tags a barrier to access? million per dose. Simply, yes, as we saw when the European Commission rejected the price point for bluebird bio’s Zynteglo.

Gene Therapy 52

Gene Therapy Gene Drugs Contamination 52